Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
32°
Cloudy
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Bristol/Myers Squibb Co
Recent news which mentions Bristol/Myers Squibb Co
< Previous
1
2
Next >
Healthy Returns: J&J cell therapy gains new edge over Bristol Myers rival
April 09, 2024
Tags
Johnson & Johnson
Science
Biotech and Pharmaceuticals
From
CNBC.com News
Judge rejects AstraZeneca’s challenge to Medicare drug price negotiations
March 01, 2024
Tags
Companies
AstraZeneca PLC
Health care industry
From
CNBC.com News
Federal judge tosses lobbying group's lawsuit challenging Medicare drug price negotiations
February 13, 2024
Tags
Breaking News: Politics
Pharmaceuticals
Law and Regulation
From
CNBC.com News
Senators to question Merck, J&J and Bristol Myers Squibb CEOs over high U.S. drug pricing
February 08, 2024
Tags
Business News
Biotechnology
Biotech and Pharmaceuticals
From
CNBC.com News
Fourth-quarter earnings are shaping up to be the best of 2023, but there's a catch
February 02, 2024
Tags
Merck & Co Inc
Chevron Corp
Earnings
From
CNBC.com News
Bristol Myers Squibb results top estimates as new drugs post strong sales growth
February 02, 2024
Tags
Pharmaceuticals
Health & Science
Bristol/Myers Squibb Co
From
CNBC.com News
Healthy Returns: J&J, Merck and Bristol Myers Squibb are in the hot seat
January 30, 2024
Tags
Biotech and Pharmaceuticals
Johnson & Johnson
Merck & Co Inc
From
CNBC.com News
5 things to know before the stock market opens Monday
January 29, 2024
Tags
Peloton Interactive Inc
Politics
Pfizer Inc
From
CNBC.com News
Big pharma is at a crossroads, as J&J, Merck and others prepare to lose heaps of revenue from blockbuster drugs
January 28, 2024
Tags
Amgen Inc
Karuna Therapeutics Inc
Teva Pharmaceutical Industries Ltd
From
CNBC.com News
Merck, Johnson & Johnson CEOs agree to testify in Senate hearing on high drug prices
January 26, 2024
Tags
Health & Science
Pharmaceuticals
Bristol/Myers Squibb Co
From
CNBC.com News
Bristol-Myers CEO talks new acquisitions: 'We are writing the next chapter of this company'
January 08, 2024
Tags
Business
Investment strategy
Investment Strategy
From
CNBC.com News
Cramer cheers Monday's tech gains, but tells investors to keep a diverse portfolio with an eye towards health care
January 08, 2024
Tags
Apple Inc
JPMORGAN DRN
Stock markets
From
CNBC.com News
Cramer names biopharma companies to watch as industry mergers start to pile up
January 05, 2024
Tags
Business
Investment strategy
RayzeBio Inc
From
CNBC.com News
Cramer's week ahead: Earnings season kicks off after JPMorgan Healthcare Conference
January 05, 2024
Tags
Amerisourcebergen Corp
Abbott Laboratories
NVIDIA Corp
From
CNBC.com News
Biden administration's Medicare drug price negotiations will face major tests in 2024
December 28, 2023
Tags
Politics
Bristol/Myers Squibb Co
Health & Science
From
CNBC.com News
Karuna Therapeutics surges 47% after Bristol Myers Squibb announces $14 billion deal
December 22, 2023
Tags
Science
US: News
Biotech and Pharmaceuticals
From
CNBC.com News
Jim Cramer explains how FTC chair Lina Khan is hurting investor portfolios
December 18, 2023
Tags
Microsoft Corp
Business
US STEEL DRN
From
CNBC.com News
Pfizer shares fall as 2024 revenue and profit forecast disappoints
December 13, 2023
Tags
Pfizer Inc
Earnings
US: News
From
CNBC.com News
Jim Cramer explains why it's hard to be bullish on the healthcare sector
November 30, 2023
Tags
Mad Money
Stock markets
Humana Inc
From
CNBC.com News
Here are 16 stocks Jim Cramer is watching, including Microsoft, Chevron, Southwest
October 30, 2023
Tags
Abbvie Inc
Comcast Corp
Datadog Inc
From
CNBC.com News
Bristol Myers Squibb earnings top estimates even as top-selling drug fights generic competition
October 26, 2023
Tags
Biotechnology
Biotech and Pharmaceuticals
Business News
From
CNBC.com News
Cramer's Lightning Round: Sell Fisker
October 23, 2023
Tags
Business
Nu Holdings Ltd
Investment strategy
From
CNBC.com News
5 things to know before the stock market opens Monday
October 23, 2023
Tags
Technology
Amazon/com Inc
Meta Platforms Inc
From
CNBC.com News
Top Wall Street analysts favor these five dividend stocks during tumultuous times
October 22, 2023
Tags
U/S/ Markets
Investing
Bristol/Myers Squibb Co
From
CNBC.com News
Drugmakers opt in to Medicare drug price negotiations – here's what happens next
October 02, 2023
Tags
Business News
Biotech and Pharmaceuticals
Biotechnology
From
CNBC.com News
Federal judge declines to block Medicare price negotiations
September 29, 2023
Tags
Lawsuits
Health care industry
Business
From
CNBC.com News
AstraZeneca, Boehringer Ingelheim to participate in Medicare drug price negotiations
September 27, 2023
Tags
AstraZeneca PLC
Bristol/Myers Squibb Co
Health & Science
From
CNBC.com News
Top Wall Street analysts are bullish on these dividend stocks
September 24, 2023
Tags
Commentary
U/S/ Markets
Broadcom Inc
From
CNBC.com News
Judge withdraws from Medicare drug price case after stock ownership is revealed
September 01, 2023
Tags
Johnson & Johnson
US: News
Merck & Co Inc
From
CNBC.com News
Medicare drug price negotiations may have a muted impact on drugmakers in the near term
August 30, 2023
Tags
Merck & Co Inc
US: News
Johnson & Johnson
From
CNBC.com News
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.